AYAL Capital Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-197,119
Closed -$7.53M 48
2026
Q1
$7.53M Sell
197,119
-67,881
-26% -$2.15M 2.04% 14
2025
Q4
$5.78M Buy
265,000
+56,029
+27% +$1.16M 2.02% 14
2025
Q3
$4.49M Sell
208,971
-31,200
-13% -$700K 1.77% 23
2025
Q2
$6.16M Buy
240,171
+141,500
+143% +$4.14M 1.47% 18
2025
Q1
$3.61M Buy
+98,671
New +$3.39M 1.19% 32

Other funds holding ATEX

AYAL Capital Advisors's ATEX Position: Q2 2026 in Review

AYAL Capital Advisors sold out of Anterix (ATEX) in Q2 2026, closing a stake of 197,119 shares — an estimated $7.53M sold.

AYAL Capital Advisors first reported a position in ATEX in Q1 2025 and held it in 5 quarters. The position peaked at $7.53M in Q1 2026. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • AYAL Capital Advisors reported no remaining Anterix position as of Q2 2026 after selling out during the quarter.
  • AYAL Capital Advisors sold 197,119 Anterix shares in Q2 2026, an estimated $7.53M.
  • AYAL Capital Advisors first reported a position in Anterix in Q1 2025 and held it in 5 quarters.
  • AYAL Capital Advisors's Anterix position peaked at $7.53M in Q1 2026.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on AYAL Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.